Photosensitizer Repositioning Affords an Enantiocomplementary Enzyme for [2 + 2]‐Cycloadditions
Angewandte Chemie International Edition · 25.08.2025 · 64 (35)
DOI: 10.1002/anie.202503576 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 04.07.2025. Verfasst von Chuanjie Sun und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry & Manchester Institute of Biotechnology, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK. Hauptthemen laut MEDLINE: Photosensitizing Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Human Frontier Science Program research, Doctoral Prize Fellowship, Henry Royce Institute for Advanced Materials.
Abstract (Originalsprache)
The combination of genetic code expansion and directed evolution has recently given rise to enantioselective photoenzymes for [2 + 2]‐cycloadditions of quinolone and indole derivatives. However, the enzymes reported to date only allow access to one enantiomeric series of the strained cyclobutane products. Here, guided by a crystal structure of our previously engineered enzyme EnT1.3, we show how judicious repositioning of the genetically programmed benzophenone photosensitizer affords an enantiocomplementary [2 + 2]‐cyclase, CEnT1.0. Following directed evolution, a proficient and oxygen‐tolerant photoenzyme (CEnT1.4) emerged that promotes [2 + 2]‐cycloadditions of a quinolone derivative with exquisite enantiocontrol (99% e.e .) and substantially enhanced regioselectivity compared with EnT1.3 (r.r. 62:1 vs. 9:1). Structural analysis of CEnT1.4, coupled with molecular dynamic simulations, reveals a well‐sculpted active site pocket that pre‐organises the substrate for regio‐ and enantioselective catalysis. This study highlights the versatility offered by genetically programmed (photo)catalytic elements when developing enzymes for altered stereochemical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry & Manchester Institute of Biotechnology, The University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK.
ORCID-Profile: Rebecca Crawshaw, Anthony P Green
Förderung
- Human Frontier Science Program research
- Doctoral Prize Fellowship
- Henry Royce Institute for Advanced Materials
- Biotechnology and Biological Sciences Research Council
- UKRI Frontier Research Guarantee
- UKRI Engineering Biology Mission award
- EPSRC and UKRI
Zitieren
APA
Sun, C., Kohn, A. R., Smithson, R., Hardy, F. J., Trimble, J. S., Cao, Y., Johannissen, L. O., Hay, S., Crawshaw, R., & Green, A. P. (2025). Photosensitizer Repositioning Affords an Enantiocomplementary Enzyme for [2 + 2]‐Cycloadditions. Angewandte Chemie International Edition, 64(35). https://doi.org/10.1002/anie.202503576
Vancouver
Sun C, Kohn AR, Smithson R, Hardy FJ, Trimble JS, Cao Y, et al. Photosensitizer Repositioning Affords an Enantiocomplementary Enzyme for [2 + 2]‐Cycloadditions. Angewandte Chemie International Edition. 2025;64(35). doi:10.1002/anie.202503576
BibTeX
@article{Sun2025,
author = {Sun, Chuanjie and Kohn, Anna R and Smithson, Ross and Hardy, Florence J and Trimble, Jonathan S and Cao, Yuanxin and Johannissen, Linus O and Hay, Sam and Crawshaw, Rebecca and Green, Anthony P},
title = {Photosensitizer Repositioning Affords an Enantiocomplementary Enzyme for [2 + 2]‐Cycloadditions},
journal = {Angewandte Chemie International Edition},
year = {2025},
volume = {64},
number = {35},
doi = {10.1002/anie.202503576}
}
EUVIMED